Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200728048241N1Phase 3Completed
Phase 3, open-label trial of ciprofloxacin and betamethasone in chronic otitis media (COM) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Otorrhea, Graft success and 2 more. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200728048241N1.